ReviewCancers2023
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities.
Anna Maria Frustaci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it
ReviewCancers2023
Anna Maria Frustaci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.